Bioethics

BOTH

Shell Companies · Financial Services

Price

$0.01

+0.00 (+0.00%)

Market Cap

$18,360

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+31.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.1M (2020) → 1.5M (2024)

Bioethics, Ltd. (ticker: BOTH) appears to be a shell company registered in the financial services sector. Shell companies typically hold assets, intellectual property, or cash rather than running a traditional business with products and customers. They often serve as legal structures for mergers, acquisitions, or special-purpose transactions.

The company generates little to no revenue, which is reflected in its 0% gross and operating margins. Shell companies like this one are usually incorporated in jurisdictions with favorable regulations and may operate globally depending on their purpose. The unusually high ROIC figure of 35.5% alongside zero revenue is a data anomaly that likely reflects minimal capital on the books rather than genuine business performance. The main risk for investors is the lack of transparent operations, making it very difficult to assess what this entity actually owns, owes, or plans to do.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+32.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

Research and development spending

Insider Activity

89.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$14,664 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Bioethics has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial